Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
In February 2026, full results from the REDEFINE 2 study showed CagriSema achieving 23% weight loss at 84 weeks but falling short of its primary endpoint under the treatment policy estimand (which measures efficacy across all patients regardless of whether they completed treatment, rather than only those who remained on it)
Methods 2.1 Participants In all, this study recruited 101 child participants between 8-12 years old that were either autistic (ASD) or without neurodevelopmental conditions (TDC)
receive a nutritional guide and recommendations
Lazzati A, Iannelli A, Schneck AS, et al
US$ 27.67
US$ 23.60
US$ 25.68
US$ 26.76
US$ 22.09
US$ 28.52
US$ 21.15
US$ 22.39
